Skip to content

Clinical trials

Phase 3 Lymphoma, Mantle-Cell trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Phase: Phase 3 Country / region: Portugal Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20102
20121
20132
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC2
BeOne Medicines1
Celgene1
European Organisation for Research and Treatment of Cancer - EORTC1
Fondazione Italiana Linfomi - ETS1
Loxo Oncology, Inc.1
Millennium Pharmaceuticals, Inc.1
The Lymphoma Academic Research Organisation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell9
Lymphoma, Non-Hodgkin4
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, Follicular2
Lymphoma, Large B-Cell, Diffuse2
Waldenstrom Macroglobulinemia2
Blast Crisis1
Breast Neoplasms1
Bronchiolitis Obliterans Syndrome1
Burkitt Lymphoma1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.